Seer Inc. share price logo

Seer Inc. Share Price

NASDAQ: SEER

Small Cap

$2.07

-0.02

(-0.96%)

as on

Seer Inc. Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.03
    $2.09
    downward going graph

    1.93%

    Downside

    0.97%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.62
    $2.63
    downward going graph

    21.74%

    Downside

    26.81%

    Upside

    downward going graph

Seer Inc. share price movements today

Previous Close
$2.09
Open
$2.03
Volume
168.3K
Day's Low - High
$2.03 - $2.09
52 Week Low - High
$1.62 - $2.63

Seer Inc. Historical Returns

1 Month Return
+ 0.97 %
3 Month Return
+ 6.63 %
1 Year Return
+ 21.51 %
3 Year Return
-75.32 %
5 Year Return
0 %

Seer Inc. Stock Fundamentals & Key Indicators

Check Seer Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$114.9M

EPS (TTM)

-1.3424

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.19

Industry PE ratio

-3.9281873111782475

P/B Ratio

0

PEG Ratio

0

EBITDA

-82.8M

Revenue (TTM)

16.3M

Profit Margin

0.00%

Return On Equity TTM

46045400.00%

Seer Inc. Stock Valuation

Track how Seer Inc. P/E has moved over time to understand its valuation trends.

Seer Inc. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Today (-1.19x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.19x

Seer Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Seer Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Seer Inc. image
Seer Inc.
BUY$114.9MNA-1.190.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.5B252.04%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$39.0BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$100.3B44.17%27.8531.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Seer Inc. Stock including INR - Dollar returns

The Seer Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Seer Inc. investment value today

Current value as on today

₹1,24,947

Returns

₹24,947

(+24.95%)

Returns from Seer Inc. Stock

₹20,349 (+20.35%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Seer Inc. Stock

Based on 9 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 9 analysts, 66.67% of analysts recommend a 'BUY' rating for Seer Inc.. Average target price of $3

Seer Inc. Share Price Target

Get share price movements and forecasts by analysts on Seer Inc..

What analysts predicted

31%UPSIDE

Target Price

$3

Current Price

$2.07

Analyzed by

9 Analysts

Target

$3.00

Seer Inc. target price $3, a slight upside of 31% compared to current price of $2.07. According to 9 analysts rating.

Seer Inc. Stock's Interest Amongst Investors

Search interest for Seer Inc. Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:10% versus previous 30 day period

Seer Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
3
3
3
4
3
3
3
3
4
4
Gross Profit
1
1
1
0
0
0
1
1
2
2
Operating Income
-27
-27
-25
-22
-25
-27
-24
-23
-20
-20
EBITDA
-26
-26
-24
-20
-23
-25
-22
-21
-19
-17
Interest Expense
1
-
-
1
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-23
-23
-21
-17
-20
-22
-21
-21
-19
-19
Income Tax Expense
-3
-4
-4
12
1
-
-
0
0
0
Net Income
-20
-23
-21
-17
-20
-22
-21
-21
-19
-19
Net Profit Margin
-550.65%
-675.24%
-552.91%
-425.81%
-674.46%
-743.82%
-541.05%
-550.57%
-474.39%
-479.49%

Seer Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
0
0
6
14
15
13
Gross Profit
0
0
0
3
6
7
6
Operating Income
-6
-16
-33
-71
-97
-103
-100
EBITDA
-6
-15
-31
-68
-93
-97
-93
Interest Expense
-
0
0
0
0
-
-
Depreciation
0
0
1
2
3
5
6
Income Before Tax
-6
-16
-32
-71
-92
-86
-86
Income Tax Expense
0
0
-1
-2
-4
5
0
Net Income
-6
-16
-31
-68
-88
-86
-86
Net Profit Margin
0.00%
-27660.34%
-4751.37%
-1073.40%
-604.00%
-568.28%
-620.91%

Seer Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-23
-21
-17
-20
-22
-21
-21
-19
-19
Operating Cash Flow
-15
-14
-10
-10
-10
-14
-11
-11
-14
Investing Cash Flow
22
-5
6
32
-8
26
15
24
7
Financing Cash Flow
0
0
0
-
-3
-6
-1
-1
-7
Change in Cash
8
-20
-3
21
-22
5
3
11
-14

Seer Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-16
-32
-71
-92
-86
-86
Operating Cash Flow
-13
-20
-46
-60
-59
-46
Investing Cash Flow
-72
-34
-170
-122
37
65
Financing Cash Flow
72
371
116
3
0
-11
Change in Cash
-13
316
-100
-179
-20
8

Global Institutional Holdings in Seer Inc.

Funds
Holdings
SoftBank Group Corp
9.12%
Siren, L.L.C.
7.1%
BlackRock Inc
4.59%
Vanguard Group Inc
3.87%
Acadian Asset Management LLC
3.82%
See all

Insights on Seer Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -21.74M → -19.42M (in $), with an average increase of 5.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 191.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 50.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 4.20M → 4.05M (in $), with an average decrease of 3.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, SEER stock has moved down by -75.3%

About Seer Inc.

seer, inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. the company develops proteograph product suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. it intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. seer, inc. has a collaboration program agreement with discovery life sciences, llc; and commercial agreements with bruker scientific llc and thermo electron north america llc. the company was formerly known as seer biosciences, inc. and changed its name to seer, inc. in july 2018. seer, inc. was incorporated in 2017 and is headquartered in redwood
OrganisationSeer Inc.
Headquarters3800 Bridge Parkway, Redwood City, CA, United States, 94065
IndustryTechnology
CEODr. Omid C. Farokhzad M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Seer Inc.

Name

Title

Mr. David R. Horn

President,Treasurer & CFO

Kenny Ross

Chief Operations & Product Officer

Ms. Marissa Dixon

Chief People Officer

Dr. Serafim Batzoglou Ph.D.

Chief Data Officer

Mr. Martin Goldberg Ph.D.

Senior Vice President of Product Development

Dr. Asim Siddiqui Ph.D.

Senior Vice President of Research & Tech Development

Dr. Omid C. Farokhzad M.D., Ph.D.

Founder, CEO, & Chair of the Board of Directors

FAQs

What is Seer Inc. share price today?

Seer Inc. share price today is $2.07 as on at the close of the market. Seer Inc. share today touched a day high of $2.09 and a low of $2.03.

What is the 52 week high and 52 week low for Seer Inc. share?

Seer Inc. share touched a 52 week high of $2.63 on and a 52 week low of $1.62 on . Seer Inc. stock price today i.e. is closed at $2.07,which is 21.14% down from its 52 week high and 27.78% up from its 52 week low.

What is Seer Inc.'s market capitalisation today?

Seer Inc. market capitalisation is $0.00T as on .

How to invest in Seer Inc. Stock (SEER) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Seer Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Seer Inc. Shares that will get you 0.7246 shares as per Seer Inc. share price of $2.07 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Seer Inc. Stock (SEER) from India?

Indian investors can start investing in Seer Inc. (SEER) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Seer Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Seer Inc. share’s latest price of $2.07 as on September 18, 2025 at 1:29 am IST, you will get 4.8309 shares of Seer Inc.. Learn more about fractional shares .